HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in Fruzaqla® (Fruquintinib) Sales by Takeda
合一医药将获得首笔商业里程碑付款,由武田公司销售的Fruzaqla®(富魁替尼)销售额超过2亿美元
HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in Fruzaqla® (Fruquintinib) Sales by Takeda
合一医药将获得首笔商业里程碑付款,由武田公司销售的Fruzaqla®(富魁替尼)销售额超过2亿美元
使用浏览器的分享功能,分享给你的好友吧